Synceres Biosciences
PrivateLast Round
Series A
Extension
Jun 15, 2023
Total Funding Raised
$14.92M
Company Overview
Synceres Biosciences is a synthetic biology company that develops and produces bio-based ingredients for industries including biomedicine, health food, and industrial chemicals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synceres Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Synceres Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 15, 2023 | ||||
| Series A | Mar 16, 2022 | ||||
| Angel | Oct 22, 2020 | ||||
| Pre Seed | Jul 24, 2019 |
Synceres Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bloomage International Group | Series A Extension |
| Tasly Holding Group | Series A Extension |
| Shenzhen New Henglida Capital Management | Pre Seed, Series A Extension |
| CoStone Capital | Series A Extension |
| Shenzhen HTI Group | Series A |
| Shenzhen Capital Group | Pre Seed, Angel, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2019
Raised Pre Seed round with Shenzhen Capital Group and Shenzhen New Henglida Capital Management.
Synceres Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synceres Biosciences's valuation, stock price, and market status.